×

Predicting response to epigenetic drug therapy

  • US 10,619,210 B2
  • Filed: 02/09/2015
  • Issued: 04/14/2020
  • Est. Priority Date: 02/07/2014
  • Status: Active Grant
First Claim
Patent Images

1. A method comprising the step of measuring the expression of ISG20, IFI27, ISG15, IRF9, IFITM3, IRF7, IFI44L, IFITM1, OASL, IFI6, OAS2, STAT1, OAS1, MX1, IFIT1, IFI44, IFIH1, MX2 and DDX58 in a biological sample obtained from a human patient having ovarian cancer, wherein the measuring step is accomplished using an array or polymerase chain reaction.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×